Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Tirzepatide

Mounjaro, Zepbound, LY3298176

Quick Stats
Studies 183
Trials 100
Completed OBSERVATIONAL NCT05766358

Role Of Metabolic Adaptation In Weight Regain

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

In a previous study (NCT04081337), 55 participants with obesity participated on a 18-week lifestyle intervention to reduce their body weight, targeting 10% body weight loss. The participants received tirzepatide (15mg after titration) or placebo during the weight loss intervention. Before and after the lifestyle intervention, energy expenditure (48-h room indirect calorimetry) and body weight and composition (dual-X-ray absorptiometry) were measured, thus enabling the assessment of metabolic adaptation. In this study, participants having provided their consent to be re-contacted will be invited to attend the research center 12,18 and 24 months after completing the lifestyle intervention. Body weight and composition will be measured, aiming to explore the association between metabolic adaptation and changes in body weight and composition after a weight loss intervention. In addition, we will explore whether weight and fat mass changes are different between groups, and whether these effects are mediated by metabolic adaptation.

Interventions

Name: Intensive lifestyle change therapy
Type: BEHAVIORAL
Description: Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Name: Tirzepatide
Type: DRUG
Description: Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up

Primary Outcomes

Measure: Body weight
TimeFrame: 24 months
Description:

Trial Information

NCT ID

NCT05766358

Status

Completed

Study Type

OBSERVATIONAL

Sponsor

Pennington Biomedical Research Center

Last Updated

December 15, 2025